Allogenic adipose-derived mesenchymal stem cell therapy (Seoul National University Hospital)

N/A

Report date: 2026/03/08 20:00:13

Base Information

Drug NameAllogenic adipose-derived mesenchymal stem cell therapy (Seoul National University Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionStem cell replacementsImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsTendon InjuriesTennis Elbow

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesSeoul National University Hospital - Abu Dhabi

China Registration ClassN/A

Develop Information

Active CompaniesSeoul National University Hospital - Abu Dhabi

Inactive CompaniesSeoul National University Hospital

Active IndicationsTendon Injuries

Inactive IndicationsTennis Elbow

Other Information

ATC CodeN/A